Use this to reason about review-stage strategy. ISSTA review is double-anonymous and its outcome model is richer than accept/reject, so plan around the Major-Revision path from the start. Reopen the current call and dates page before making process claims — the number of deadlines and the exact mechanics change between editions.
| Criterion | What raises it | What sinks it |
|---|---|---|
| Originality | A technique or question the field did not have | A re-parameterized variant of existing work |
| Importance of contribution | A result the testing/analysis community will reuse | A narrow gain with no reuse story |
| Soundness | Claims scoped to what is actually shown | Overclaimed scope; unstated assumptions |
| Evaluation | Real subjects, fair baselines, proper statistics | Toy subjects, mis-configured baselines, single runs |
| Presentation | A clear threat model and evaluation contract | Undefined scope; results without protocol |
| Comparison to related work | Delta stated against the nearest techniques | Missing the closest competitor |
| Verifiability / transparency | Pinned subjects and a runnable artifact | Unshared subjects, unregenerable tables |
The last two — comparison and verifiability — are where testing/analysis papers most often lose avoidable ground, because the nearest baseline and the shared artifact are both checkable.
[Current stage] submitted / reviews / response / major-revision / decision / camera-ready
[Outcome model] accept / major-revision / reject
[Decision actors] <reviewers / meta-reviewer / chairs>
[Likely leverage] <soundness / evaluation / comparison / verifiability>
[Forbidden moves] <identity leak / unpromised new results in the box>
[Next response move] <one action>